Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:2168-2169
Published online before print June 22, 2006, doi: 10.1161/01.STR.0000230286.95513.c2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/8/2168    most recent
01.STR.0000230286.95513.c2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiese, K. M.
Right arrow Articles by Wang, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiese, K. M.
Right arrow Articles by Wang, D.
Related Collections
Right arrow Embolic stroke
Right arrow Thrombolysis

(Stroke. 2006;37:2168.)
© 2006 American Heart Association, Inc.


Case Reports

Intravenous Recombinant Tissue Plasminogen Activator in a Pregnant Woman With Cardioembolic Stroke

Kathleen M. Wiese, DO; Arun Talkad, MD; Maureen Mathews, APN David Wang, DO

From the Department of Neurology (K.M.W., A.T.), University of Illinois at Peoria; and the OSF Stroke Center and Network (M.M., D.W.), Illinois Neurological Institute, OSF St. Francis Medical Center, Peoria, Ill.

Correspondence to Kathleen M. Wiese, DO, University of Illinois at Peoria, OSF St. Francis Medical Center, Department of Neurology, 530 NE Glen Oak Ave, Peoria, IL 61637. E-mail kathleenwiese{at}yahoo.com

Abstract

Background and Purpose— Historically, the use of tissue plasminogen activator (tPA) thrombolysis in pregnancy has been regarded as relatively contraindicated. Underlying this stance has been the concern over the risk of bleeding complications in both mother and child.

Summary of Case— We report the successful use of intravenous recombinant tPA (rtPA) thrombolysis in a pregnant woman with acute cardioembolic stroke.

Conclusions— The patient improved clinically, did not develop complications after receiving rtPA, and at 37 weeks’ gestation, delivered a healthy infant, demonstrating that rtPA thrombolysis may be used safely in pregnant women.


Key Words: thrombolysis • tissue plasminogen activator




This article has been cited by other articles:


Home page
StrokeHome page
J. De Keyser, Z. Gdovinova, M. Uyttenboogaart, P. C. Vroomen, and G. J. Luijckx
Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations
Stroke, September 1, 2007; 38(9): 2612 - 2618.
[Abstract] [Full Text] [PDF]